Add to Favorites Newsroom RSS Share
Tampa, FL USA

Our News on Newswise

New Study Finds Improved Vaccine That Protects against Nine Types of HPV is Highly Effective

TAMPA, Fla. – Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus...
6-Sep-2017 1:05 PM EDT Add to Favorites

Moffitt Cancer Center & Cvergenx Partner to Personalize Radiation Therapy

Moffitt’s Radiation Oncology Department will utilize Cvergenx’s Genomic-Adjusted Radiation Dose (GARD) model.
9-Aug-2017 11:05 AM EDT Add to Favorites

New Research Shows the Power of Radiomics to Improve Precision Medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules. Despite the progress that has been made in targeted cancer therapies, the...
3-Aug-2017 11:05 AM EDT Add to Favorites

Radiation Therapy Prior to Surgery Reduces the Risk of Secondary Tumors in Early-Stage Breast Cancer Patients

Moffitt researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery or after surgery. Their study found that patients who have neoadjuvant radiation therapy...
17-Jul-2017 9:05 AM EDT Add to Favorites

Experimental Drug Co-Developed by Moffitt Cancer Center Researcher Shows Promise

The investigation found that the drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway discovered by Pagano’s group.
14-Jun-2017 1:45 PM EDT Add to Favorites

International Study Identifies New Genetic Risk Factors for Testicular Cancer

Peter Kanetsky, Ph.D., M.P.H., chair of the Cancer Epidemiology Department at Moffitt Cancer Center, and colleagues from the International TEsticular CAncer Consortium (TECAC), launched a large analysis of five major testicular cancer studies to...
13-Jun-2017 9:05 AM EDT Add to Favorites

Moffitt Researchers Identify a Novel Inhibitor That Overcomes the Drug Resistance in Prostate Cancer

In a study published today in Cancer Cell, Moffitt Cancer Center researchers report that a newly discovered epigenetic mechanism can lead to the development of castration-resistant prostate cancer. They identified a novel drug that targets this...
12-Jun-2017 12:05 PM EDT Add to Favorites

Moffitt Develops Innovative Approaches to Improve Personalized Radiation Therapy for Head and Neck Cancer Patients

Moffitt researchers have developed a test called the radiosensitivity index that determines how sensitive a patient’s tumor is to radiation therapy. The radiosensitivity index is based on the expression of different genes in a patient’s tumor...
31-May-2017 10:05 AM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos





Chat now!